Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma

2012 ◽  
Vol 48 ◽  
pp. 391-401 ◽  
Author(s):  
Elena Strocchi ◽  
Francesca Fornari ◽  
Manuela Minguzzi ◽  
Laura Gramantieri ◽  
Maddalena Milazzo ◽  
...  
2021 ◽  
Vol 9 ◽  
Author(s):  
Yuting Wang ◽  
Mingyao He ◽  
Xiang Li ◽  
Jinlong Chai ◽  
Qinglin Jiang ◽  
...  

The activation of Ras small GTPases, including RalA and RalB, plays an important role in carcinogenesis, tumor progress, and metastasis. In the current study, we report the discovery of a series of 6-sulfonylamide-pyrano [2,3-c]-pyrazole derivatives as novel RalA inhibitors. ELISA-based biochemical assay results indicated that compounds 4k–4r suppressed RalA/B binding capacities to their substrates. Cellular proliferation assays indicated that these RalA inhibitors potently inhibited the proliferation of HCC cell lines, including HepG2, SMMC-7721, Hep3B, and Huh-7 cells. Among the evaluated compounds, 4p displayed good inhibitory capacities on RalA (IC50 = 0.22 μM) and HepG2 cells (IC50 = 2.28 μM). Overall, our results suggested that a novel small-molecule RalA inhibitor with a 6-sulfonylamide-pyrano [2, 3-c]-pyrazole scaffold suppressed autophagy and cell proliferation in hepatocellular carcinoma, and that it has potential for HCC-targeted therapy.


2014 ◽  
Vol 22 (21) ◽  
pp. 6201-6208 ◽  
Author(s):  
Shu-Fu Wang ◽  
Yin-Ling Zhu ◽  
Ping-Ting Zhu ◽  
Jigar A. Makawana ◽  
Ya-Liang Zhang ◽  
...  

2020 ◽  
Vol 30 (16) ◽  
pp. 127327
Author(s):  
Zhicheng Su ◽  
Tingyuan Yang ◽  
Jie Wang ◽  
Mengzhen Lai ◽  
Linjiang Tong ◽  
...  

2011 ◽  
Vol 54 (20) ◽  
pp. 7427-7431 ◽  
Author(s):  
Christine Dyrager ◽  
Linda Nilsson Möllers ◽  
Linda Karlsson Kjäll ◽  
John Patrick Alao ◽  
Peter Dinér ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document